Fourier-transform infrared (FTIR) spectroscopy can detect the presence of functional groups and molecules directly from a mixed solution of organic molecules. Although it is quite useful to monitor chemical reactions, quantitative analysis of FTIR spectra becomes difficult when various peaks of different widths overlap. To overcome this difficulty, we propose a chemometrics approach to accurately predict the concentration of components in chemical reactions, yet interpretable by humans. The proposed method first decomposes a spectrum into peaks with various widths by the wavelet transform. Subsequently, a sparse linear regression model is built using the wavelet coefficients. Models by the method are interpretable using the regression coefficients shown on Gaussian distributions with various widths. The interpretation is expected to reveal the relation of broad regions in spectra to the model prediction. In this study, we conducted the prediction of monomer concentration in copolymerization reactions of five monomers against methyl methacrylate by various chemometric approaches including conventional methods. A rigorous validation scheme revealed that the proposed method overall showed better predictive ability than various linear and non-linear regression methods. The visualization results were consistent with the interpretation obtained by another chemometric approach and qualitative evaluation. The proposed method is found to be useful for calculating the concentrations of monomers in copolymerization reactions and for the interpretation of spectra.
Ligand-based virtual screening (LBVS) and structure-based virtual screening (SBVS), and their combinations, are frequently conducted in modern drug discovery campaigns. As a form of combination, an amalgamation of methods from ligand- and structure-based information, termed hybrid VS approaches, has been extensively investigated such as using interaction fingerprints (IFPs) in combination with machine learning (ML) models. This approach has the potential to prioritize active compounds in terms of protein-ligand binding and ligand structural characteristics, which is assumed to be difficult using either one of the approaches. Herein, we present an IFP, named the fragmented interaction fingerprint (FIFI), for hybrid VS approaches. FIFI is constructed from the extended connectivity fingerprint atom environments of a ligand proximal to the protein residues in the binding site. Each unique ligand substructure within each amino acid residue is encoded as a bit in FIFI while retaining sequence order. From the retrospective evaluation of activity prediction using a limited number and variety of active compounds for six biological targets, FIFI consistently showed higher prediction accuracy than that using previously proposed IFPs. For the same data sets, the screening performance of LBVS, SBVS sequential VS, parallel VS, and other hybrid VS approaches was investigated. Compared to these approaches, FIFI in combination with ML showed overall stable and high prediction accuracy, except for one target: the kappa opioid receptor, where the extended connectivity fingerprint combined with ML models showed better performance than other approaches by wide margins.
15 December 2022 in ACS Pharmacology & Translational Science
Aim: Screening of compounds against panels of targets yields profiling matrices. Such matrices are excellent test cases for the analysis and prediction of ligand–target interactions. We made three matrices freely available that were extracted from public screening data. Methodology: A new algorithm was used to derive complete profiling matrices from assay data. Data: Two profiling matrices were derived from confirmatory assays containing 53 different targets and 109,925 and 143,310 distinct compounds, respectively. A third matrix was extracted from primary screening assays covering 171 different targets and 224,251 compounds. Next steps: Profiling matrices can be used to test computational chemogenomics methods for their ability to predict ligand–target pairs. Additional matrices will be generated for individual target families. Lay abstract Screening of a given number of small molecules in different assays produces a so-called profiling matrix. This matrix reports for each compound inactivity or activity in all assays. Such profiling matrices are frequently produced in the pharmaceutical industry but rarely disclosed. We have recently reported a computational methodology to derive such matrices from independently conducted biological assays. Herein, we describe three large profiling matrices we have extracted from many experimental screens and made publicly available. These matrices should be helpful to investigators studying the interactions of small molecules with different biological targets. Graphical abstract Shown is a small compound profiling matrix resulting from assaying four compounds (rows) against four target proteins (columns). ‘+’ and ‘−’ signs denote compound activity and inactivity, respectively.